Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3069-67-8 | MDL No. : | MFCD07779431 |
Formula : | C3H4N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NNXROHRFMWHXNH-UHFFFAOYSA-N |
M.W : | 100.08 | Pubchem ID : | 5323974 |
Synonyms : |
|
Num. heavy atoms : | 7 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 22.09 |
TPSA : | 58.89 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.07 cm/s |
Log Po/w (iLOGP) : | 0.88 |
Log Po/w (XLOGP3) : | -0.23 |
Log Po/w (WLOGP) : | -0.33 |
Log Po/w (MLOGP) : | -0.72 |
Log Po/w (SILICOS-IT) : | 1.24 |
Consensus Log Po/w : | 0.17 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.84 |
Solubility : | 14.3 mg/ml ; 0.143 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.55 |
Solubility : | 28.3 mg/ml ; 0.282 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.08 |
Solubility : | 8.3 mg/ml ; 0.083 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.9 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | at 0℃; Sealed tube; Green chemistry; Large scale | (2) Preparation of oxadiazolone:Methyl acetate 2000ml into 5000ml three bottles,Under stirring, 740 g of acetylhydrazine was added,Frozen down to 0 below, put 1680g sodium bicarbonate,Seal the reaction bottle.To the reaction bottle in the continuous access to phosgene, phosgene flow rate of 15m3 / h.After the end of the reaction, the solvent was distilled off, crystallized at 0 ° C and filtered to give a white solid 988.2 g, yield: 99percent. |
[ 1046079-35-9 ]
5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride
Similarity: 0.66
[ 24469-50-9 ]
(E)-tert-Butyl 2-benzylidenehydrazinecarboxylate
Similarity: 0.56
[ 870-46-2 ]
tert-Butyl hydrazinecarboxylate
Similarity: 0.55
[ 19740-72-8 ]
Diisopropyl hydrazine-1,2-dicarboxylate
Similarity: 0.53
[ 1046079-35-9 ]
5-(Piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one hydrochloride
Similarity: 0.66
[ 1044766-09-7 ]
5-(2-Fluorophenyl)-1,3,4-oxadiazol-2(3H)-one
Similarity: 0.51